-
Paclitaxel albumin bound by Bristol-Myers Squibb for Gallbladder Cancer: Likelihood of Approval
18 Apr 2024 03:41 GMT
… of approval.
Paclitaxel albumin bound overview
Paclitaxel (Abraxane, … non-small cell lung cancer (NSCLC), as … lung cancer, HER2 positive breast cancer, small cell lung cancer, non-small cell lung cancer … complete picture of Paclitaxel albumin bound’s …
-
ORYZON Announces U.S. FDA Clearance of CTEP-CRADA Phase I/II Clinical Trial Sponsored by NCI for Iadademstat Plus Immune Checkpoint Inhibitors in 1L Extensive Stage Small Cell Lung Cancer
08 Apr 2024 12:00 GMT
… in first line small cell lung cancer (SCLC) patients with … to render small cell lung cancer cells visible to the … tumors such as small cell lung cancer (SCLC), neuroendocrine tumors (NET … (FCCC) in combination with paclitaxel in R/R neuroendocrine …
-
Second-Line Treatment of Pancreatic Adenocarcinoma: Shedding Light on New Opportunities and Key Talking Points from Clinical Trials
18 Apr 2024 07:34 GMT
… with gemcitabine plus nab-paclitaxel or FOLFIRINOX derivative chemotherapy … in non small cell lung cancer. Both are small molecules … in non-small cell lung cancer, in the context of … pathways: targeting NRG1 fusions in lung cancer. Clin Cancer Res. 2015 …
-
Nab-Paclitaxel for Relapsed AIDS-Related Kaposi Sarcoma -A Case Report
11 Apr 2024 12:02 GMT
… , and albumin-bound paclitaxel (nab-paclitaxel), which work by … small cell lung cancer, and bladder cancer. Nab-paclitaxel is used … advanced non-small-cell lung cancer (NSCLC) was efficacious … A compressive review about taxol(®): history and future challenges …
-
Merck Initiates Phase 3 Clinical Trial of MK-1084, an Investigational Oral KRAS G12C Inhibitor, in Combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Certain Patients With Metastatic Non-Small Cell Lung Cancer
04 Apr 2024 11:01 GMT
… non-small cell lung cancers (adenocarcinoma). Despite … challenging.
About lung cancer
Lung cancer is the leading … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer … and chemotherapy (paclitaxel, paclitaxel protein-bound, or …
-
Ramucirumab by Eli Lilly and Co for Gallbladder Cancer: Likelihood of Approval
18 Apr 2024 03:41 GMT
… or in combination with paclitaxel, is indicated for the … non-small cell lung cancer with activating epidermal … squamous non-small cell lung cancer, metastatic colorectal cancer, … gallbladder cancer, small-cell lung cancer and metastatic thymic carcinoma, …
-
European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Neoadjuvant Treatment, Then Continued as Monotherapy as Adjuvant Treatment, for Resectable Non-Small Cell Lung Cancer (NSCLC) at High Risk of Recurrence in Adults
28 Mar 2024 11:00 GMT
… with metastatic lung cancer, lung cancer continues to … cycles.
About lung cancer
Lung cancer is the leading … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer … and chemotherapy (paclitaxel, paclitaxel protein-bound, or …
-
Effectiveness and Safety of Anlotinib Combined with PD-1 Blockades in Patients with Previously Immunotherapy Treated Advanced Non-Small Cell Lung Cancer: A Retrospective Exploratory Study
25 Mar 2024 10:25 GMT
… with non-small-cell lung cancer. Clin Lung Cancer. 2021;22(1 … non-small-cell lung cancer patients. Clin Lung Cancer. 2020;21( … non-small cell lung cancer (NSCLC). Transl Lung Cancer Res. 2015; … Camrelizumab plus carboplatin and paclitaxel as first-line treatment …
-
Merck Provides Update on Phase 3 KEYLYNK-006 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Maintenance LYNPARZA® (olaparib) for Certain Patients With Metastatic Nonsquamous Non-Small Cell Lung Cancer
21 Mar 2024 11:01 GMT
… non-small cell lung cancer. We sincerely … intolerable toxicity.
About lung cancer
Lung cancer is the leading … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer … carboplatin and either paclitaxel or paclitaxel protein-bound, …
-
BeiGene Receives Positive CHMP Opinion for Tislelizumab as Treatment for Non-Small Cell Lung Cancer
26 Feb 2024 10:26 GMT
… lung cancer (NSCLC) across three indications:
In combination with carboplatin and either paclitaxel … or nab-paclitaxel for the … dyspnea.
About NSCLC
Lung cancer is the second … lung cancers.2 In 2020, the number of new cases of lung cancer …